Cargando…

PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA

Detalles Bibliográficos
Autores principales:	AIYANYOR, ALFRED, KAMRAN UDDIN, Q., RAMESH, NAVITHA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503375/ http://dx.doi.org/10.1016/j.chest.2021.07.444

Ejemplares similares

SPONTANEOUS SUBCUTANEOUS EMPHYSEMA AND PNEUMOMEDIASTINUM WITH PROGRESSION TO PNEUMORETROPERITONEUM AS A RARE COMPLICATION OF COVID-19 PNEUMONIA
por: NHI NGUYEN, BAO, et al.
Publicado: (2021)

PULMONARY ASPERGILLOSIS POST-TOCILIZUMAB TREATMENT IN A PATIENT WITH COVID-19 PNEUMONIA
por: GIDWANI, VIPUL, et al.
Publicado: (2022)

ROSEOMONAS GILARDII-ASSOCIATED BACTEREMIA IN THE SETTING OF COVID-19 PNEUMONIA
por: NANGRANI, KUNAL, et al.
Publicado: (2021)

FIRST CASE OF COVID-19 COMPLICATED WITH BURKOLDERIA CEPACIA PNEUMONIA AND BACTEREMIA
por: Osman, Heba, et al.
Publicado: (2020)

Streptococcus constellatus and Prevotella bivia Penile Abscess
por: Nalmas, Sandhya, et al.
Publicado: (2007)

Nonpuerperal breast abscess due to Prevotella bivia
por: Boucher, Astrid, et al.
Publicado: (2020)

POST-COVID-19 EOSINOPHILIC PNEUMONIA
por: SHAH, DHIRAJ, et al.
Publicado: (2022)

ACTIVE TB AFTER THE USE OF TOCILIZUMAB FOR COVID-19 INFECTION
por: NOH, SUNGRYONG, et al.
Publicado: (2021)

INFECTIOUS COMPLICATIONS AFTER TOCILIZUMAB IN PATIENTS WITH COVID: A REAL-WORLD EXPERIENCE
por: LIU, HONGLI, et al.
Publicado: (2022)

RESTRICTIVE LUNG DEFECT IN POST-COVID-19 PNEUMONIA
por: TAWEESEDT, PAHNWAT, et al.
Publicado: (2021)

CASE SERIES OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN POST-COVID-19 DISEASE
por: AYUB, MAAHA, et al.
Publicado: (2021)

UNEXPECTED OPPORTUNISTIC INFECTION IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: NIEVES, HÉCTOR, et al.
Publicado: (2021)

Purulent Proctitis Caused by Prevotella bivia in a Homosexual Male
por: Masadeh, Maen, et al.
Publicado: (2016)

Prevotella bivia cardiac implantable electronic device related endocarditis
por: Fogelson, Benjamin, et al.
Publicado: (2022)

Prevotella bivia: A Rare Cause of Zuska’s Breast Disease
por: Aboud, Ameer, et al.
Publicado: (2022)

THE ADDED CLINICAL VALUE OF TOCILIZUMAB IN TREATING ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

POST-COVID-19 ORGANIZING PNEUMONIA: A RARER ENTITY THAN PREVIOUSLY IMAGINED
por: OGBONNAH, UZOAMAKA, et al.
Publicado: (2022)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

Severe preeclampsia is associated with a higher relative abundance of Prevotella bivia in the vaginal microbiota
por: Lin, Chia-Ying, et al.
Publicado: (2020)

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020)

INTRIGUING STUDY OF PULMONARY FUNCTION TESTS POST-COVID-19 PNEUMONIA IN A HISPANIC-DOMINANT POPULATION
por: CHOUDHURY, SAIARA, et al.
Publicado: (2022)

E. COLI PNEUMONIA WITH PNEUMATOCELE, EMPYEMA NECESSITANS, AND BRONCHOPLEURAL FISTULA IN A PATIENT WITH SEVERE COVID-19
por: Kahn, Michael, et al.
Publicado: (2020)

POST-COVID-19 SYNDROME: CHARACTERIZATION OF A COHORT AND ASSOCIATION WITH ACUTE DISEASE SEVERITY
por: OLIVEIRA BAPTISTA DA SILVA, FERNANDA, et al.
Publicado: (2021)

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ISOLATION FROM PLEURAL FLUID WITH COVID-19 PNEUMONIA AND SUPERIMPOSED EMPYEMA
por: Leys, Lorenzo, et al.
Publicado: (2020)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

LETHAL FUNGEMIA IN COVID-19 PNEUMONIA
por: PLEMMONS, ANNA, et al.
Publicado: (2021)

TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA
por: AHMED, MUBASHIR AYAZ, et al.
Publicado: (2022)

THORACIC ULTRASOUND IN COVID-19: USE OF LUNG AND DIAPHRAGM ULTRASOUND IN EVALUATING DYSPNEA IN SURVIVORS OF CRITICAL ILLNESS FROM COVID-19 PNEUMONIA IN A POST-ICU CLINIC
por: ISLAM, MARJAN, et al.
Publicado: (2022)

BILATERAL PNEUMOTHORACES IN A PATIENT WITH COVID PNEUMONIA
por: Ul Haq, Irfan, et al.
Publicado: (2020)

Studies on the pathogenicity of anaerobes, especially Prevotella bivia, in a rat pyometra model.
por: Mikamo, H, et al.
Publicado: (1998)

D-DIMER AS A SURROGATE MARKER OF DISEASE SEVERITY IN AFRICAN AMERICAN POPULATION WITH COVID-19 PNEUMONIA: A COMMUNITY HOSPITAL RETROSPECTIVE STUDY
por: OMORE, IBRAHIM, et al.
Publicado: (2021)

NOT EVERYTHING IS COVID: PERSISTENT FEVER AND MALAISE MIMICKING COVID-19 PNEUMONIA
por: ATUAKA, CHRISTIANA, et al.
Publicado: (2021)

CLINICAL OUTCOMES OF PATIENTS WITH ASTHMA WITH COVID-19 PNEUMONIA
por: Brinton, Taylor, et al.
Publicado: (2020)

LEAKY LUNGS: A COMPLICATION OF COVID-19 PNEUMONIA
por: ADHIKARI, PRAKASH, et al.
Publicado: (2021)

A COMPARISON OF THE INCIDENCE OF VENTILATOR-ASSOCIATED PNEUMONIA AMONG PATIENTS WITH COVID-19 AND INFLUENZA PNEUMONIA A AND B
por: GROSSMAN, J., et al.
Publicado: (2022)

POST-COVID-19 ASPERGILLOSIS
por: BAIG, MARIA HAIDER
Publicado: (2022)

UPFRONT COMMUNITY-ACQUIRED PNEUMONIA ANTIMICROBIAL THERAPY IS ASSOCIATED WITH REDUCED RATES OF VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH COVID-19
por: WAKEFIELD, CONNOR, et al.
Publicado: (2022)

GUILLAIN-BARRÉ SYNDROME FOLLOWING COVID-19 PNEUMONIA: ARE THEY RELATED?
por: THOMAS, AKESH, et al.
Publicado: (2021)

DEXAMETHASONE-INDUCED HICCUPS IN A PATIENT WITH COVID-19 PNEUMONIA
por: HASIB KHALIL, MUHAMMAD
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7s7m3ad5sobtfcfp6b7p6keb2l